Redline Pharmacy Recalls Morphine Sulfate Due to Processing Control Deficiencies
Redline Pharmacy Solutions is recalling Morphine Sulfate 20 mg/mL intrathecal syringes due to a lack of processing controls. The product was sold to patients in Nebraska.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA has classified this recall as Class II. Per the rubric, an FDA Class II recall is assigned a severity score of 4 (Severe), as it indicates a potential for temporary or medically reversible adverse health consequences.
Plain-English summary
Redline Pharmacy Solutions is recalling Morphine Sulfate, 20 mg/mL intrathecal, 20 mL per syringe. The recall was initiated because of a lack of processing controls during the manufacturing or preparation of the product.
The affected product is identified by Lot 02242020@2. According to the source text, the product was sold to patients in Nebraska. The FDA has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
Patients who have received this specific lot of Morphine Sulfate should contact their healthcare provider or pharmacist for further instructions on how to proceed. No specific instructions for disposal or return are provided in the source text.
The recalled product
- Product
- Morphine Sulfate, 20 mg/mL intrathecal, 20 mL per syringe. Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901
- Manufacturer
- Redline Pharmacy Solutions
- Category
- Drug — Injectable
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot 02242020@2
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 6 recalled by Redline Pharmacy Solutions under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 6 products in this recall →Related recalls
Same manufacturer · Redline Pharmacy Solutions
See all →- SevereRedline Pharmacy Recalls Morphine Sulfate Due to Processing Controls
FDA (Drugs) · 2020-03-18
- SevereRedline Pharmacy Recalls Ertapenem Injectable Due to Processing Control Issues
FDA (Drugs) · 2020-03-18
- ModerateRedline Pharmacy Recalls Acetylcysteine Ophthalmic Solution Due to Processing Controls
FDA (Drugs) · 2020-03-18
- SevereRedline Pharmacy Recalls Vancomycin Injectable Due to Processing Control Deficiencies
FDA (Drugs) · 2020-03-18
- ModerateRedline Pharmacy Recalls Daptomycin Injectable Due to Processing Control Issues
FDA (Drugs) · 2020-03-18
Same hazard · processing control deficiency
See all →- ModerateDoxycycline oral suspension recalled for insanitary manufacturing conditions
FDA (Drugs) · 2022-07-13
- ModerateMasterPharm Recalls Testosterone/Anastrozole Pellets Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateConversio Health Recalls Albuterol and Ipratropium Inhalation Vials
FDA (Drugs) · 2019-11-27
- ModerateKroger Specialty Pharmacy Recalls Bethkis Ampules Due to Processing Control Issues
FDA (Drugs) · 2018-05-16
- ModerateKroger Specialty Pharmacy Recalls Dupixent Due to Processing Control Issues
FDA (Drugs) · 2018-05-16